Authors: Ambrose, PG Grasela, DM Grasela, TH Passarell, J Mayer, HB Pierce, PF

Citation: Pg. Ambrose et al., Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections, ANTIM AG CH, 45(10), 2001, pp. 2793-2797

Authors: Phillips, L Grasela, TH Agnew, JR Ludwig, EA Thompson, GA

Citation: L. Phillips et al., A population pharmacokinetic-pharmacodynamic analysis and model validationof azimilide, CLIN PHARM, 70(4), 2001, pp. 370-383

Authors: Wang, ECY Grasela, TH Walawander, CA

Citation: Ecy. Wang et al., Applying epidemiology-based outcomes research to clinical decision-making - A hypothetical model of biotechnology therapy in gram-negative sepsis, PHARMACOECO, 15(4), 1999, pp. 385-393

Authors: Fleishaker, JC Fiedler-Kelly, J Grasela, TH

Citation: Jc. Fleishaker et al., Population pharmacokinetics of tirilazad: Effects of weight, gender, concomitant phenytoin, and subarachnoid hemorrhage, PHARM RES, 16(4), 1999, pp. 575-583

Authors: Grasela, TH Fiedler-Kelly, J Cox, E Womble, GP Risner, ME Chen, C

Citation: Th. Grasela et al., Population pharmacokinetics of lamotrigine adjunctive therapy in adults with epilepsy, J CLIN PHAR, 39(4), 1999, pp. 373-384